Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if renal cell (kidney) cancer that has spread to
other parts of the body will respond to treatment with motexafin gadolinium (MGd).